• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MENTOR TEXAS MENTOR TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MENTOR TEXAS MENTOR TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE Back to Search Results
Catalog Number 3504307M
Device Problem Activation Failure (3270)
Patient Problem No Code Available (3191)
Event Date 01/31/2019
Event Type  Injury  
Manufacturer Narrative
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A device history record review is in progress.Once completed, a supplemental report will be submitted.Manufacturer¿s reference number: (b)(4).
 
Event Description
It was reported that a patient had a 550cc mentor tissue expander implanted that the right sided expander could not be sufficiently filled with saline during the procedure.As a result, the device was replaced with another 550cc mentor tissue expander.
 
Manufacturer Narrative
The investigation of the returned device was completed by the failure analysis lab on 9/13/2019.Device evaluation summary: according to the reported information, the customer experienced difficulty adding or removing saline solution to the tissue expander during surgery.During evaluation of the device it appeared intact.Leak testing was performed in accordance with mentor procedures and no leak sites were detected, but difficulty with valve expansion occurred.The analysis was¿unable to determine the root cause for difficulty with fluid addition or removal due to the defective valve.Excessive manipulation may have caused the failure; however, this cannot be conclusively determined.It should be noted that as part of our quality process, each device is visually inspected during manufacturing to ensure the device meets the required specifications prior to shipment.Manufacturer¿s reference number: (b)(4).
 
Manufacturer Narrative
A manufacturing record evaluation (mre) was performed for the finished device number 7412048 on 3/8/3019, and no non-conformance's related to the reported complaint condition were identified.Manufacturer¿s reference number: (b)(4).
 
Manufacturer Narrative
The mentor failure analysis lab received the device for evaluation on 8/5/2019.The analysis has begun but is not complete at this time.When the investigational analysis has been completed, a supplemental report will be submitted.Along with the device the serial number was obtained.Manufacturer¿s reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MENTOR TISSUE EXPANDER
Type of Device
EXPANDER, SKIN, INFLATABLE
Manufacturer (Section D)
MENTOR TEXAS
3041 skyway circle north
irving TX 75038
MDR Report Key8401346
MDR Text Key138153463
Report Number1645337-2019-09070
Device Sequence Number1
Product Code LCJ
UDI-Device Identifier00081317002437
UDI-Public00081317002437
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup,Followup
Report Date 02/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/15/2021
Device Catalogue Number3504307M
Device Lot Number7412048
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/05/2019
Initial Date Manufacturer Received 02/12/2019
Initial Date FDA Received03/07/2019
Supplement Dates Manufacturer Received03/08/2019
08/05/2019
09/13/2019
Supplement Dates FDA Received04/01/2019
08/30/2019
09/18/2019
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-